Survodutide
A Study to Test Different Doses of BI 456906 in Patients With Obesity
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 131
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| BI 456906 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |